Toxic epidermal necrolysis associated with treatment for preterm labor

Dermatology

Volumn 196, Issue 4, 1998, Pages 461-462

  Ciaessens, N ^a   Delbeke, L ^b   Lambert, J ^b   Matthieu, L ^b   Lafaire, C ^b   Van Marck, E ^b  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b Ziekenhuis Stuivenberg   (Belgium)

Author keywords

Betamethasone; Indomethacin; Pregnancy; Ritodrine; Toxic epidermal necrolysis

Indexed keywords

BETAMETHASONE; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; RITODRINE; STEROID; UTERUS SPASMOLYTIC AGENT;

ADULT; ARTICLE; CASE REPORT; FEMALE; GESTATIONAL AGE; HUMAN; PREMATURE LABOR; PRIORITY JOURNAL; TOXIC EPIDERMAL NECROLYSIS;

ADULT; BETAMETHASONE; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; GESTATIONAL AGE; GLUCOCORTICOIDS; HUMANS; INDOMETHACIN; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY COMPLICATIONS; RITODRINE; TOCOLYSIS; TOCOLYTIC AGENTS;

EID: 0031832449     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017950     Document Type: Article

References (15)

1. S. Karger AG 1 Lyell A: Toxic epidermal necrolysis: An eruption resembling scalding of the skin. Br J Dermatol 1956;68:355-361.
2. Roujeau JC: The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: A clinical classification. J Invest Dermatol 1994; 102:285-305.
3. Revuz JE, Roujeau JC: Toxic epidermal necrolysis; in Arndt KA, Leboit PE, Robinson JK, Wintroub BU (eds): Cutaneous Medicine and Surgery: An Integrated Program in Dermatology. Philadelphia, Saunders, 1996, pp 704-711.
4. Roujeau JC, Stem RS: Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 331:1272-1285.
5. Blacker KL, Stern RS, Wintroub BU: Cutaneous reactions to drugs; in Fitzpatrick TB, Eisen AZ, Wolff K, Friedberg IM (eds): Dermatology in General Medicine, ed 4. New York, McGraw-Hill, 1993, pp 1783-1793.
6. Lyell A: A review of toxic epidermal necrolysis in Britain. Br J Dermatol 1967:79:662-671.
7. Beitner O, Hod M, Friedman S, Ovadia J, Mimouni M: Ritodrine-induced erythema multiforme. Drug Intell Clin Pharmacol 1988;22: 724.
8. O'Sullivan M, Hanly JG, Molloy M: A case of toxic epidermal necrolysis secondary to indomethacin. Br J Rheumatol 1983;22:47-19.
9. Lear JT, English JSC: Toxic epidermal necrolysis associated with indomethacin therapy. Postgrad MedJ 1996;72:186-189.
10. Roujeau JC, Guillaume JC, Fahre JP, Penso D, Fléchet M, Girre J: Toxic epidermal necrolysis (Lyell syndrome): Incidence and drug etiology in France 1981-1985. Arch Dermatol 1990; 126:37-42.
11. Solinas A, Cottoni F, Tanda F, Tocco A: Toxic epidermal necrolysis in a patient affected by mixed essential cryoglobulinemia. J Am Acad Dermatol 1988;18:1165-1169.
12. Rzany B, Schmitt H, Schöpf E. Toxic epidermal necrolysis in patients receiving glucocorticosteroids. Acta Derm Vénéréol 1991 ;71 : 171-172.
13. Roujeau J, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, Auquier A: Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Enal J Med 1995;333:1600-1607.
14. Jurecka W: Impact of pregnancy on skin diseases; in Harahap M, Wallach RC (eds): Skin Changes and Diseases in Pregnancy. New York, Dekker, 1996, pp 91-127.
15. Paquet P, Nikkels A, Arrese JE, Vanderkelen A, Piérard GE: Macrophages and tumor necrosis factor alfa in toxic epidermal necrolysis. ArchDermatol 1994; 130:605-608.